A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Novo Integrated Sciences Inc.’s current trading price is -71.00% away from its 52-week high, while its distance from the 52-week low is 442.17%. The stock’s price range for this time frame has been between $0.07 and $1.29. The trading volume of the company’s shares in the Healthcare reached around 16.61 million for the day, which was evidently lower than the average daily volume of 42.93 million over the last three months.
Novo Integrated Sciences Inc. (NVOS) current stock price is $0.37. During the last trading session, the stock soared, reaching $0.50 after opening at $0.48. The stock’s lowest point was $0.3348 before it closed at $0.43.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Novo Integrated Sciences Inc.’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $1.29 on 09/16/22, with the lowest value being $0.07 on 08/14/23.
How Financial Performance Impacts Market Capitalization
Novo Integrated Sciences Inc. (NVOS) has experienced a quarterly rise of 178.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 53.72M and boasts a workforce of 115 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1557, with a change in price of +0.2670. Similarly, Novo Integrated Sciences Inc. recorded 31,324,924 in trading volume during the last 100 days, posting a change of +248.84%.
How NVOS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NVOS stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.00.
NVOS Stock Stochastic Average
The raw stochastic average for Novo Integrated Sciences Inc. over the last 50 days is presently at 65.04%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 61.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 70.34% and 78.28%, respectively.
NVOS Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 86.03%. However, over the last six months, the performance has been weaker by 223.90%. The price of NVOS increased 106.57% over the last 30 days. And in the last five days, it has surged by 39.85%.
